These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1812438)

  • 21. Challenges and progress in the development of a serogroup B meningococcal vaccine.
    Lewis S; Sadarangani M; Hoe JC; Pollard AJ
    Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a meningococcal vaccine.
    Poolman JT
    Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial.
    Wedege E; Bjune G; Frøholm LO; Høiby EA; Rosenqvist E
    NIPH Ann; 1991 Dec; 14(2):183-4; discussion 185-6. PubMed ID: 1812431
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.
    Vipond C; Suker J; Jones C; Tang C; Feavers IM; Wheeler JX
    Proteomics; 2006 Jun; 6(11):3400-13. PubMed ID: 16645985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.
    Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S
    Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.
    Zollinger WD; Boslego J; Moran E; Garcia J; Cruz C; Ruiz S; Brandt B; Martinez M; Arthur J; Underwood P
    NIPH Ann; 1991 Dec; 14(2):211-2; discussion 213. PubMed ID: 1812433
    [No Abstract]   [Full Text] [Related]  

  • 29. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory.
    de Kleijn ED; de Groot R; Lafeber AB; Labadie J; van Limpt CJ; Visser J; Berbers GA; van Alphen L; Rümke HC
    J Infect Dis; 2001 Jul; 184(1):98-102. PubMed ID: 11398116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.
    Uli L; Castellanos-Serra L; Betancourt L; Domínguez F; Barberá R; Sotolongo F; Guillén G; Pajón Feyt R
    Proteomics; 2006 Jun; 6(11):3389-99. PubMed ID: 16673438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci.
    Poolman JT; Beuvery EC; Hopman CT; Witvliet MH; Timmermans HA; Teerlink T; Zanen HC
    Dev Biol Stand; 1986; 63():147-52. PubMed ID: 3091433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.
    Wong SH; Lennon DR; Jackson CM; Stewart JM; Reid S; Ypma E; O'Hallahan JM; Oster P; Mulholland K; Martin DR
    Pediatr Infect Dis J; 2009 May; 28(5):385-90. PubMed ID: 19384263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine.
    Claassen I; Meylis J; van der Ley P; Peeters C; Brons H; Robert J; Borsboom D; van der Ark A; van Straaten I; Roholl P; Kuipers B; Poolman J
    Vaccine; 1996 Jul; 14(10):1001-8. PubMed ID: 8873395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
    Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
    Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease.
    Frasch CE; Tsai CM; Mocca LF
    Clin Invest Med; 1986; 9(2):101-7. PubMed ID: 3089660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-meningococcal vaccines].
    Taha MK; Alonso JM
    Rev Prat; 2008 Dec; 58(19):2099-101. PubMed ID: 19213536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.
    Nøkleby H; Aavitsland P; O'Hallahan J; Feiring B; Tilman S; Oster P
    Vaccine; 2007 Apr; 25(16):3080-4. PubMed ID: 17287053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.